Insider Transactions in Q1 2025 at Harmony Biosciences Holdings, Inc. (HRMY)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 27
2025
|
Sandip Kapadia CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,775
-100.0%
|
$67,450
$38.05 P/Share
|
|
Jan 27
2025
|
Jeffrey Dierks CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,629
-100.0%
|
$61,902
$38.02 P/Share
|
|
Jan 24
2025
|
Kumar Budur CHIEF MEDICAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,151
-52.63%
|
$43,738
$38.01 P/Share
|
|
Jan 24
2025
|
Kumar Budur CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,187
+50.0%
|
-
|
|
Jan 24
2025
|
Sandip Kapadia CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
2,037
-53.44%
|
$77,406
$38.01 P/Share
|
|
Jan 24
2025
|
Sandip Kapadia CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
3,812
+50.0%
|
-
|
|
Jan 24
2025
|
Jeffrey M. Dayno PRESIDENT, CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,567
-43.5%
|
$173,546
$38.01 P/Share
|
|
Jan 24
2025
|
Jeffrey M. Dayno PRESIDENT, CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,500
+50.0%
|
-
|
|
Jan 24
2025
|
Jeffrey Dierks CHIEF COMMERCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,058
-39.37%
|
$40,204
$38.01 P/Share
|
|
Jan 24
2025
|
Jeffrey Dierks CHIEF COMMERCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
15,812
+50.0%
|
$237,180
$15.35 P/Share
|
|
Jan 24
2025
|
Jeffrey Dierks CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
13,125
-80.48%
|
$485,625
$37.4 P/Share
|
|
Jan 24
2025
|
Andrew Serafin CHIEF STRATEGY OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
865
-34.6%
|
$32,870
$38.01 P/Share
|
|
Jan 24
2025
|
Andrew Serafin CHIEF STRATEGY OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+50.0%
|
-
|
|
Jan 21
2025
|
Sandip Kapadia CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
25,000
-100.0%
|
$1,000,000
$40.18 P/Share
|
|
Jan 21
2025
|
Sandip Kapadia CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+50.0%
|
$725,000
$29.03 P/Share
|
|
Jan 21
2025
|
Jeffrey M. Dayno PRESIDENT, CEO |
SELL
Open market or private sale
|
Direct |
19,293
-100.0%
|
$771,720
$40.13 P/Share
|
|
Jan 21
2025
|
Jeffrey M. Dayno PRESIDENT, CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
19,293
+50.0%
|
$154,344
$8.22 P/Share
|
|
Jan 21
2025
|
Jeffrey Dierks CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,123
-100.0%
|
$44,920
$40.0 P/Share
|
|
Jan 21
2025
|
Jeffrey Dierks CHIEF COMMERCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,123
+50.0%
|
$37,059
$33.44 P/Share
|
|
Jan 16
2025
|
Jeffrey Dierks CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
29,475
-100.0%
|
$1,090,575
$37.41 P/Share
|
|
Jan 16
2025
|
Jeffrey Dierks CHIEF COMMERCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
29,475
+50.0%
|
$972,675
$33.44 P/Share
|
|
Jan 15
2025
|
Jeffrey Dierks CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
10,507
-100.0%
|
$388,759
$37.01 P/Share
|
|
Jan 15
2025
|
Jeffrey Dierks CHIEF COMMERCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
10,507
+50.0%
|
$346,731
$33.44 P/Share
|
|
Jan 13
2025
|
Jeffrey Dierks CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
7,180
-100.0%
|
$265,660
$37.04 P/Share
|
|
Jan 13
2025
|
Jeffrey Dierks CHIEF COMMERCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
7,180
+50.0%
|
$236,940
$33.44 P/Share
|